Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ascendis Pharma A/SSH(ASND) | 10,108,400 | 9,710,428 | -397,972 | $1.38B | $1.45B | 16.72% | +$71.28M |
| Vaxcyte, Inc.SH(PCVX) | 8,203,754 | 8,689,190 | +485,436 | $619.47M | $992.91M | 11.45% | +$373.45M |
| Janux Therapeutics, Inc.SH(JANX) | 9,165,652 | 9,165,652 | 0 | $383.95M | $416.40M | 4.80% | +$32.45M |
| Legend Biotech CorporationSH(LEGN) | 7,506,934 | 7,506,934 | 0 | $332.48M | $365.81M | 4.22% | +$33.33M |
| Rhythm Pharmaceuticals, Inc.SH(RYTM) | 6,084,412 | 6,084,412 | 0 | $249.83M | $318.76M | 3.68% | +$68.94M |
| Avidity Biosciences IncSH | 5,400,408 | 6,300,408 | +900,000 | $220.61M | $289.38M | 3.34% | +$68.77M |
| Tyra Biosciences, Inc.SH(TYRA) | 10,416,609 | 10,416,609 | 0 | $166.56M | $244.89M | 2.82% | +$78.33M |
| Evolent Health, Inc.SH(EVH) | 8,514,862 | 8,514,862 | 0 | $162.80M | $240.80M | 2.78% | +$78.00M |
| Edgewise Therapeutics, Inc.SH(EWTX) | 8,909,091 | 8,909,091 | 0 | $160.45M | $237.78M | 2.74% | +$77.33M |
| Biogen Inc.SH(BIIB) | 982,139 | 1,184,456 | +202,317 | $227.68M | $229.59M | 2.65% | +$1.92M |
| Dyne Therapeutics, Inc.SH(DYN) | 6,049,204 | 6,381,144 | +331,940 | $213.48M | $229.21M | 2.64% | +$15.73M |
| RxSight, Inc.SH(RXST) | 3,694,825 | 3,916,825 | +222,000 | $222.32M | $193.61M | 2.23% | -$28.71M |
| Bicara Therapeutics IncSH | 0 | 6,955,993 | +6,955,993 | $0 | $177.17M | 2.04% | +$177.17M |
| Climb Bio, Inc.SH(CLYM) | 31,419,267 | 31,419,267 | 0 | $223.39M | $159.92M | 1.84% | -$63.47M |
| ARS Pharmaceuticals, Inc.SH(SPRY) | 10,860,977 | 10,860,977 | 0 | $92.43M | $157.48M | 1.82% | +$65.06M |
| Arcellx IncSH COMMON STOCK | 1,604,014 | 1,851,479 | +247,465 | $88.53M | $154.62M | 1.78% | +$66.09M |
| Artiva Biotherapeutics, Inc.SH(ARTV) | 0 | 9,853,302 | +9,853,302 | $0 | $152.23M | 1.76% | +$152.23M |
| Wave Life Sciences, Inc.SH(WVE) | 18,202,009 | 18,202,009 | 0 | $90.83M | $149.26M | 1.72% | +$58.43M |
| Geron CorporationSH(GERN) | 46,202,425 | 32,285,755 | -13,916,670 | $195.90M | $146.58M | 1.69% | -$49.32M |
| Verona Pharma Plc - AdrSH | 7,632,646 | 5,009,653 | -2,622,993 | $110.37M | $144.13M | 1.66% | +$33.76M |
| Newamsterdam Pharma Co NvSH ORDINARY SHARES | 8,064,000 | 8,064,000 | 0 | $154.91M | $133.86M | 1.54% | -$21.05M |
| Apogee Therapeutics IncSH | 1,961,863 | 1,961,863 | 0 | $77.20M | $115.24M | 1.33% | +$38.04M |
| Day One Biopharmaceuticals ISH COM | 7,871,721 | 7,871,721 | 0 | $108.47M | $109.65M | 1.26% | +$1.18M |
| 89bio IncSH | 14,175,398 | 14,175,398 | 0 | $113.54M | $104.90M | 1.21% | -$8.65M |
| Recursion Pharmaceuticals, Inc.SH(RXRX) | 15,384,615 | 15,384,615 | 0 | $115.38M | $101.38M | 1.17% | -$14.00M |
| LENZ Therapeutics, Inc.SH(LENZ) | 4,178,823 | 4,178,823 | 0 | $72.25M | $99.21M | 1.14% | +$26.95M |
| PepGen Inc.SH(PEPG) | 10,689,545 | 10,689,545 | 0 | $170.61M | $91.40M | 1.05% | -$79.21M |
| Axsome Therapeutics, Inc.SH(AXSM) | 1,000,000 | 1,000,000 | 0 | $80.50M | $89.87M | 1.04% | +$9.37M |
| Structure Therapeutics IncSH | 1,896,772 | 1,896,772 | 0 | $74.49M | $83.25M | 0.96% | +$8.76M |
| Tourmaline Bio IncSH | 2,538,925 | 2,538,925 | 0 | $32.65M | $65.28M | 0.75% | +$32.63M |
| Dianthus Therapeutics, Inc.SH(DNTH) | 2,333,000 | 2,333,000 | 0 | $60.38M | $63.88M | 0.74% | +$3.50M |
| Mineralys Therapeutics, Inc.SH(MLYS) | 4,850,984 | 4,850,984 | 0 | $56.76M | $58.75M | 0.68% | +$1.99M |
| Acrivon Therapeutics IncSH | 8,340,508 | 8,340,508 | 0 | $48.37M | $58.38M | 0.67% | +$10.01M |
| Astria Therapeutics IncSH | 5,043,756 | 5,105,213 | +61,457 | $45.90M | $56.21M | 0.65% | +$10.31M |
| 4d Molecular Therapeutics InSH | 5,098,211 | 5,098,211 | 0 | $107.01M | $55.11M | 0.64% | -$51.90M |
| CG Oncology, Inc.SH(CGON) | 1,397,433 | 1,397,433 | 0 | $44.12M | $52.73M | 0.61% | +$8.61M |
| Bicycle Therapeutics Plc-AdrSH | 2,253,000 | 2,253,000 | 0 | $45.60M | $50.99M | 0.59% | +$5.38M |
| Nkarta, Inc.SH(NKTX) | 10,805,129 | 10,805,129 | 0 | $63.86M | $48.84M | 0.56% | -$15.02M |
| BioAge Labs, Inc.SH(BIOA) | 0 | 2,210,589 | +2,210,589 | $0 | $45.98M | 0.53% | +$45.98M |
| GH Research PLCSH(GHRS) | 6,601,689 | 6,686,689 | +85,000 | $76.98M | $44.73M | 0.52% | -$32.24M |
| Praxis Precision Medicines, Inc.SH(PRAX) | 1,235,599 | 761,955 | -473,644 | $51.10M | $43.84M | 0.51% | -$7.26M |
| IDEAYA Biosciences, Inc.SH(IDYA) | 0 | 1,347,252 | +1,347,252 | $0 | $42.68M | 0.49% | +$42.68M |
| Larimar Therapeutics, Inc.SH(LRMR) | 6,045,351 | 6,045,351 | 0 | $43.83M | $39.60M | 0.46% | -$4.23M |
| MBX Biosciences, Inc.SH(MBX) | 0 | 1,511,334 | +1,511,334 | $0 | $39.26M | 0.45% | +$39.26M |
| Acumen Pharmaceuticals, Inc.SH(ABOS) | 14,932,063 | 14,932,063 | 0 | $36.14M | $37.03M | 0.43% | +$895.9K |
| Fulcrum Therapeutics, Inc.SH(FULC) | 11,609,704 | 10,229,099 | -1,380,605 | $71.98M | $36.52M | 0.42% | -$35.46M |
| Iteos Therapeutics IncSH | 3,517,259 | 3,184,711 | -332,548 | $52.20M | $32.52M | 0.37% | -$19.68M |
| Solid Biosciences IncSH | 4,330,446 | 4,330,446 | 0 | $24.55M | $30.18M | 0.35% | +$5.63M |
| C4 Therapeutics, Inc.SH(CCCC) | 4,878,000 | 4,878,000 | 0 | $22.54M | $27.80M | 0.32% | +$5.27M |
| Enliven Therapeutics IncSH | 2,122,465 | 1,061,233 | -1,061,232 | $49.60M | $27.10M | 0.31% | -$22.50M |
| Alto Neuroscience, Inc.SH(ANRO) | 2,085,554 | 2,075,154 | -10,400 | $22.29M | $23.74M | 0.27% | +$1.45M |
| Sera Prognostics, Inc.SH(SERA) | 3,032,808 | 3,032,808 | 0 | $17.95M | $23.66M | 0.27% | +$5.70M |
| Taysha Gene Therapies, Inc.SH(TSHA) | 10,872,503 | 10,872,503 | 0 | $24.35M | $21.85M | 0.25% | -$2.50M |
| Immatics N.V.SH(IMTX) | 1,750,000 | 1,750,000 | 0 | $20.34M | $19.97M | 0.23% | -$367.5K |
| Aerovate Therapeutics IncSH | 9,192,092 | 9,192,092 | 0 | $15.26M | $19.21M | 0.22% | +$3.95M |
| Nuvalent Inc-ASH | 119,789 | 176,281 | +56,492 | $9.09M | $18.03M | 0.21% | +$8.95M |
| Third Harmonic Bio IncSH | 2,033,056 | 1,280,826 | -752,230 | $26.43M | $17.36M | 0.20% | -$9.07M |
| Vor Biopharma Inc.SH(VOR) | 22,748,880 | 22,748,880 | 0 | $22.75M | $15.92M | 0.18% | -$6.82M |
| Insmed IncorporatedSH(INSM) | 200,000 | 200,000 | 0 | $13.40M | $14.60M | 0.17% | +$1.20M |
| Pliant Therapeutics, Inc.SH(PLRX) | 1,281,000 | 1,281,000 | 0 | $13.77M | $14.36M | 0.17% | +$589.3K |
| Tenaya Therapeutics, Inc.SH(TNYA) | 7,622,347 | 6,982,587 | -639,760 | $23.63M | $13.48M | 0.16% | -$10.15M |
| Zura Bio LimitedSH(ZURA) | 3,217,503 | 3,217,503 | 0 | $11.26M | $13.06M | 0.15% | +$1.80M |
| Werewolf Therapeutics, Inc.SH(HOWL) | 6,144,881 | 6,144,881 | 0 | $14.99M | $13.03M | 0.15% | -$1.97M |
| CervoMed Inc.SH(CRVO) | 817,120 | 817,120 | 0 | $13.99M | $11.93M | 0.14% | -$2.06M |
| Xencor, Inc.SH(XNCR) | 0 | 575,000 | +575,000 | $0 | $11.56M | 0.13% | +$11.56M |
| Adicet Bio IncSH | 7,541,000 | 7,541,000 | 0 | $9.12M | $10.86M | 0.13% | +$1.73M |
| Arvinas, Inc.SH(ARVN) | 421,348 | 421,348 | 0 | $11.22M | $10.38M | 0.12% | -$838.5K |
| Avalo Therapeutics, Inc.SH(AVTX) | 0 | 967,000 | +967,000 | $0 | $9.19M | 0.11% | +$9.19M |
| Chimerix IncSH | 8,800,000 | 8,800,000 | 0 | $7.71M | $8.18M | 0.09% | +$475.2K |
| Boundless Bio, Inc.SH(BOLD) | 2,180,631 | 2,180,631 | 0 | $8.44M | $7.57M | 0.09% | -$872.3K |
| Cidara Thereapeutics IncSH | 0 | 703,080 | +703,080 | $0 | $7.56M | 0.09% | +$7.56M |
| Perceptive Capital SolutionsSH CL A ORD SHS | 750,000 | 750,000 | 0 | $7.54M | $7.51M | 0.09% | -$30.0K |
| Lexeo Therapeutics, Inc.SH(LXEO) | 672,712 | 546,554 | -126,158 | $10.79M | $4.94M | 0.06% | -$5.85M |
| Protara Therapeutics, Inc.SH(TARA) | 1,900,000 | 1,900,000 | 0 | $3.95M | $3.48M | 0.04% | -$475.0K |
| Adagio Medical Holdings, Inc.SH(ADGM) | 0 | 1,333,926 | +1,333,926 | $0 | $3.44M | 0.04% | +$3.44M |
| Surrozen, Inc.SH(SRZN) | 282,580 | 282,580 | 0 | $3.09M | $3.39M | 0.04% | +$291.1K |
| Metagenomi Therapeutics, Inc.SH(MGX) | 1,477,749 | 1,305,239 | -172,510 | $6.03M | $2.83M | 0.03% | -$3.20M |
| Newamsterdam Pharma Co Nv-27SH *W EXP 99/99/999 | 333,333 | 333,333 | 0 | $2.91M | $2.33M | 0.03% | -$573.3K |
| An2 Therapeutics IncSH | 5,551,295 | 1,999,997 | -3,551,298 | $11.94M | $2.14M | 0.02% | -$9.80M |
| Regulus Therapeutics IncSH | 6,250,000 | 766,834 | -5,483,166 | $11.16M | $1.20M | 0.01% | -$9.95M |
| Scilex Holding CompanySH(SCLX) | 261,179 | 261,179 | 0 | $504.1K | $241.5K | 0.00% | -$262.6K |
| Cybin D/B/A Helus PharmaSH(HELP) | 44,004,464 | 0 | -44,004,464 | $11.93M | $0 | — | -$11.93M |
| Longboard Pharmaceuticals InSH | 3,289,119 | 0 | -3,289,119 | $88.90M | $0 | — | -$88.90M |
| MacroGenics, Inc.SH(MGNX) | 2,082,021 | 0 | -2,082,021 | $8.85M | $0 | — | -$8.85M |
| Unicycive Therapeutics IncSH | 2,632,200 | 0 | -2,632,200 | $1.32M | $0 | — | -$1.32M |
| UroGen Pharma Ltd.SH(URGN) | 3,083,430 | 0 | -3,083,430 | $51.74M | $0 | — | -$51.74M |
| Nurix Therapeutics, Inc.SH(NRIX) | 650,000 | 0 | -650,000 | $13.57M | $0 | — | -$13.57M |